Oliva, F. D., Scobie, M., Patel, A., Foucar, C., Baidya, R., Rodgers, T., … Lin, C. (2025). Treatment Response and Safety of Ponatinib and Asciminib in Patients With Chronic Myeloid Leukemia: A National Veterans Health Administration Analysis. In CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (Vol. 25).

Oliva, Francyess Denis, Micaela Scobie, Anand Patel, Charles Foucar, Robin Baidya, Thomas Rodgers, Daphne Friedman, Michael Kelley, and Chenyu Lin. “Treatment Response and Safety of Ponatinib and Asciminib in Patients With Chronic Myeloid Leukemia: A National Veterans Health Administration Analysis.” In CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, Vol. 25, 2025.

Oliva FD, Scobie M, Patel A, Foucar C, Baidya R, Rodgers T, et al. Treatment Response and Safety of Ponatinib and Asciminib in Patients With Chronic Myeloid Leukemia: A National Veterans Health Administration Analysis. In: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2025.

Oliva, Francyess Denis, et al. “Treatment Response and Safety of Ponatinib and Asciminib in Patients With Chronic Myeloid Leukemia: A National Veterans Health Administration Analysis.” CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol. 25, 2025.

Oliva FD, Scobie M, Patel A, Foucar C, Baidya R, Rodgers T, Friedman D, Kelley M, Lin C. Treatment Response and Safety of Ponatinib and Asciminib in Patients With Chronic Myeloid Leukemia: A National Veterans Health Administration Analysis. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2025.